Ardelyx (ARDX) Short Interest Ratio & Short Volume → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free ARDX Stock Alerts $6.78 +0.17 (+2.57%) (As of 05:26 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ardelyx Short Interest DataCurrent Short Interest33,040,000 sharesPrevious Short Interest35,170,000 sharesChange Vs. Previous Month-6.06%Dollar Volume Sold Short$259.36 millionShort Interest Ratio5.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares232,700,000 sharesPercentage of Shares Shorted14.20%Today's Trading Volume3,304,554 sharesAverage Trading Volume5,922,320 sharesToday's Volume Vs. Average56% Short Selling Ardelyx ? Sign up to receive the latest short interest report for Ardelyx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartARDX Short Interest Over TimeARDX Days to Cover Over TimeARDX Percentage of Float Shorted Over Time Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. Ardelyx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202433,040,000 shares $259.36 million -6.1%N/A5.9 $7.85 4/30/202435,170,000 shares $225.09 million +3.7%N/A5.9 $6.40 4/15/202433,930,000 shares $230.72 million -3.1%N/A6.2 $6.80 3/31/202435,020,000 shares $255.65 million -3.6%N/A5.5 $7.30 3/15/202436,310,000 shares $294.11 million +8.0%N/A5.8 $8.10 2/29/202433,610,000 shares $313.25 million +11.8%N/A5.1 $9.32 Get the Latest News and Ratings for ARDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ardelyx and its competitors with MarketBeat's FREE daily newsletter. 2/15/202430,060,000 shares $279.56 million +6.8%N/A4.7 $9.30 1/31/202428,160,000 shares $245.84 million -3.0%N/A4.7 $8.73 1/15/202429,020,000 shares $262.05 million -12.0%N/A4.5 $9.03 12/31/202332,980,000 shares $204.48 million +0.2%N/A4.6 $6.20 12/15/202332,930,000 shares $194.62 million -8.7%N/A5.1 $5.91 11/30/202336,080,000 shares $162.72 million -5.4%N/A5.7 $4.51 11/15/202338,120,000 shares $147.52 million +4.5%N/A5.6 $3.87 10/31/202336,470,000 shares $144.06 million +50.0%N/A5.4 $3.95 10/15/202324,310,000 shares $80.95 million +9.7%N/A3.8 $3.33 9/30/202322,170,000 shares $90.45 million -9.6%N/A4.6 $4.08 9/15/202324,510,000 shares $111.52 million -4.9%N/A4.6 $4.55 8/31/202325,770,000 shares $109.78 million -7.1%N/A5 $4.26 8/15/202327,750,000 shares $106.84 million +0.2%N/A6 $3.85 7/31/202327,700,000 shares $109.14 million +4.3%N/A5.5 $3.94 7/15/202326,560,000 shares $90.30 million +1.7%N/A5.2 $3.40 6/30/202326,130,000 shares $88.58 million +42.0%N/A4.7 $3.39 6/15/202318,400,000 shares $72.13 million +7.3%N/A3.1 $3.92 5/31/202317,150,000 shares $57.28 million +2.8%N/A2.8 $3.34 5/15/202316,690,000 shares $74.44 million -8.5%N/A2.3 $4.46 4/30/202318,240,000 shares $81.35 million -4.0%N/A2.6 $4.46 4/15/202319,000,000 shares $89.49 million +7.2%N/A2.7 $4.71 3/31/202317,720,000 shares $84.88 million +36.4%N/A2.4 $4.79 3/15/202312,990,000 shares $51.83 million +18.2%N/A1.6 $3.99 2/28/202310,990,000 shares $31.65 million +8.7%N/A1.4 $2.88 2/15/202310,110,000 shares $30.53 million -4.4%N/A1.4 $3.02 1/31/202310,580,000 shares $31.00 million -9.5%N/A1 $2.93 1/15/202311,690,000 shares $36.94 million -5.5%N/A1.1 $3.16 12/30/202212,370,000 shares $35.25 million +17.6%N/A1.3 $2.85 12/15/202210,520,000 shares $20.41 million -15.2%N/A1.2 $1.94 11/30/202212,410,000 shares $21.35 million +44.5%N/A1.5 $1.72 11/15/20228,590,000 shares $10.48 million +17.0%N/A1.1 $1.22 10/31/20227,340,000 shares $11.01 million -7.6%N/A2.1 $1.50 10/15/20227,940,000 shares $10.96 million +2.1%N/A2.4 $1.38 9/30/20227,780,000 shares $9.26 million +12.9%N/A2.4 $1.19Kiss of death from Joe Biden (Ad)I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. 9/15/20226,890,000 shares $9.44 million -14.9%N/A2.1 $1.37 8/31/20228,100,000 shares $7.68 million -4.0%N/A2.5 $0.95 8/15/20228,440,000 shares $8.19 million -22.4%N/A3.4 $0.97 7/31/202210,880,000 shares $7.59 million +0.4%N/A4.5 $0.70 7/15/202210,840,000 shares $7.58 million +3.5%N/A3.4 $0.70 6/30/202210,470,000 shares $6.18 million -13.9%N/A3.1 $0.59 6/15/202212,160,000 shares $6.66 million -6.2%N/A3.4 $0.55 5/31/202212,960,000 shares $8.50 million +11.2%N/A4 $0.66 5/15/202211,660,000 shares $7.62 million +1.0%N/A3.3 $0.65 4/30/202211,540,000 shares $9.50 million +20.0%N/A3.2 $0.82 4/15/20229,620,000 shares $8.59 million -1.4%N/A2.7 $0.89 3/31/20229,760,000 shares $10.44 million +3.7%N/A3.1 $1.07 3/15/20229,410,000 shares $8.65 million +9.8%N/A2.5 $0.92 2/28/20228,570,000 shares $6.60 million +1.1%N/A1.1 $0.77 2/15/20228,480,000 shares $6.21 million +15.9%N/A0.5 $0.73 1/31/20227,320,000 shares $6.05 million -7.0%N/A0.4 $0.83 1/15/20227,870,000 shares $7.33 million -1.8%N/A0.5 $0.93 12/31/20218,010,000 shares $8.81 million -34.5%N/A0.5 $1.10 12/15/202112,230,000 shares $14.68 million +92.9%13.1%0.7 $1.20 11/30/20216,340,000 shares $7.23 million +7.6%6.9%0.4 $1.14 11/15/20215,890,000 shares $6.60 million -23.4%6.5%1.7 $1.12 10/29/20217,690,000 shares $9.30 million +18.5%9.3%1.9 $1.21 10/15/20216,490,000 shares $7.01 million -2.0%7.7%0.9 $1.08 9/30/20216,620,000 shares $8.74 million -16.0%7.8%0.6 $1.32 9/15/20217,880,000 shares $10.01 million -8.8%9.3%0.8 $1.27 8/31/20218,640,000 shares $12.18 million -15.5%10.3%0.8 $1.41 8/13/202110,230,000 shares $14.73 million -3.4%13.1%1.1 $1.44 7/30/202110,590,000 shares $18.43 million +7.2%14.2%1.2 $1.74 7/15/20219,880,000 shares $74.00 million +8.1%13.2%1.7 $7.49 6/30/20219,140,000 shares $69.28 million +20.9%12.3%4.1 $7.58 6/15/20217,560,000 shares $55.19 million -10.0%10.1%3.4 $7.30 5/28/20218,400,000 shares $60.06 million -10.1%11.3%3.9 $7.15 5/14/20219,340,000 shares $62.02 million +5.2%N/A4.4 $6.64 4/30/20218,880,000 shares $74.86 million -11.4%N/A4.4 $8.43 4/15/202110,020,000 shares $78.56 million +13.1%N/A6.2 $7.84 3/31/20218,860,000 shares $54.93 million +54.4%N/A8.3 $6.20 3/15/20215,740,000 shares $40.01 million +23.7%N/A6.7 $6.97 2/26/20214,640,000 shares $30.02 million -4.1%N/A5.7 $6.47 2/12/20214,840,000 shares $35.19 million +4.5%N/A6.5 $7.27 1/29/20214,630,000 shares $31.81 million +2.2%N/A6.7 $6.87 1/15/20214,530,000 shares $31.39 million -5.2%N/A6.9 $6.93 12/31/20204,780,000 shares $32.17 million -4.0%N/A8.1 $6.73 12/15/20204,980,000 shares $34.26 million -14.6%N/A9.1 $6.88 11/30/20205,830,000 shares $36.79 million +13.0%N/A12 $6.31 11/15/20205,160,000 shares $29.88 million -9.3%N/A10.7 $5.79 10/30/20205,690,000 shares $29.76 million +12.7%N/A12 $5.23 10/15/20205,050,000 shares $28.46 million -8.0%N/A10.1 $5.64 9/30/20205,490,000 shares $28.82 million -7.3%N/A0 $5.25 9/15/20205,920,000 shares $36.05 million -6.6%N/A9.5 $6.09 8/31/20206,340,000 shares $36.39 million -2.5%N/A10.2 $5.74Kiss of death from Joe Biden (Ad)I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. 8/14/20206,500,000 shares $36.47 million +9.4%N/A9.9 $5.61 7/31/20205,940,000 shares $33.56 million -3.6%N/A8.3 $5.65 7/15/20206,160,000 shares $39.36 million +13.2%N/A8.4 $6.39 6/30/20205,440,000 shares $37.64 million +68.9%N/A7.1 $6.92 6/15/20203,220,000 shares $21.22 million +10.3%N/A4.4 $6.59 5/29/20202,920,000 shares $21.40 million +4.3%N/A3.8 $7.33 5/15/20202,800,000 shares $20.78 million +0.4%N/A3.5 $7.42 4/30/20202,790,000 shares $18.36 million -5.7%N/A3.2 $6.58 4/15/20202,960,000 shares $19.80 million -2.6%N/A3.5 $6.69 3/31/20203,040,000 shares $22.89 million -13.5%N/A3.6 $7.53 3/13/20203,514,700 shares $21.30 million +9.5%N/A4.4 $6.06 2/28/20203,210,000 shares $18.49 million +14.2%N/A3.7 $5.76 2/14/20202,810,000 shares $17.53 million +10.6%N/A2.7 $6.24 1/31/20202,540,000 shares $17.37 million +6.7%N/A2.6 $6.84 1/15/20202,380,000 shares $17.68 million -39.6%N/A2.6 $7.43 12/31/20193,940,000 shares $27.93 million +42.8%6.3%4.4 $7.09 ARDX Short Interest - Frequently Asked Questions What is Ardelyx's current short interest? Short interest is the volume of Ardelyx shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 33,040,000 shares of ARDX short. Learn More on Ardelyx's current short interest. What is a good short interest ratio for Ardelyx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARDX shares currently have a short interest ratio of 6.0. Learn More on Ardelyx's short interest ratio. Which institutional investors are shorting Ardelyx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ardelyx: Jane Street Group LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Ardelyx's short interest increasing or decreasing? Ardelyx saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 33,040,000 shares, a decline of 6.1% from the previous total of 35,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ardelyx's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ardelyx: Mirum Pharmaceuticals, Inc. (18.69%), OPKO Health, Inc. (26.01%), 89bio, Inc. (10.29%), XBiotech Inc. (3.65%), Organon & Co. (3.16%), BridgeBio Pharma, Inc. (11.26%), Cytokinetics, Incorporated (14.05%), Apellis Pharmaceuticals, Inc. (10.37%), Madrigal Pharmaceuticals, Inc. (19.57%), Alpine Immune Sciences, Inc. (5.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Ardelyx stock? Short selling ARDX is an investing strategy that aims to generate trading profit from Ardelyx as its price is falling. ARDX shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ardelyx? A short squeeze for Ardelyx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARDX, which in turn drives the price of the stock up even further. How often is Ardelyx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARDX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Mirum Pharmaceuticals Short Interest Data OPKO Health Short Interest Data 89bio Short Interest Data XBiotech Short Interest Data Organon & Co. Short Interest Data BridgeBio Pharma Short Interest Data Cytokinetics Short Interest Data Apellis Pharmaceuticals Short Interest Data Madrigal Pharmaceuticals Short Interest Data Alpine Immune Sciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARDX) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardelyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.